We characterized a mutant protein C gene from an individual with no detectable protein C antigen in blood plasma. Southern blot hybridization analysis with human protein C cDNA demonstrated neither gross deletion nor rearrangement of the gene. Sequencing all the exons and exon-intron boundaries of the gene except the 3' noncoding region showed two mutant alleles. The one, derived from the mother, represents a deletion of 5 nucleotides (nt) (CCCGC) in the end of exon VI (mutation I), predicted to result in the generation of a new stop codon due to a reading frameshift and the premature termination of translation. The other, derived from the father, represents a point mutation (G to A) in exon IX (mutation 11). resulting in an amino acid substitution, Gly-376(GGC) to Asp(GAC), in the catalytic domain of ROTEIN C is a precursor of a vitamin K-dependent P serine protease that plays an important role in the regulation of blood coagulation.14 It is synthesized in the liver as a single-chain polypeptide, consisting of a 42-amino acid preproleader sequence and a light chain of 155 amino acids connected to a 262-residue heavy chain with a connecting dipeptide of Lys-Arg. During the processing, the preproleader sequence and the connecting dipeptide are removed, giving rise to a two-chain molecule linked by a disulfide
P serine protease that plays an important role in the regulation of blood coagulation.14 It is synthesized in the liver as a single-chain polypeptide, consisting of a 42-amino acid preproleader sequence and a light chain of 155 amino acids connected to a 262-residue heavy chain with a connecting dipeptide of Lys-Arg. During the processing, the preproleader sequence and the connecting dipeptide are removed, giving rise to a two-chain molecule linked by a disulfide
The two-chain form is activated by thrombin in the presence of an endothelial cofactor, thrombomodulin, through the proteolytic removal of a 12-residue activation peptide from the amino terminus of the heavy Activated protein C exerts its anticoagulant function by proteolytic degradation of factors Va and VIIIa in the presence of protein S?-" Its anticoagulant activity is regulated by cwl-protease inhibitorr2 and protein C inhibiIt may stimulate fibrinolysis by neutralizing tissue plasminogen activator inhibitor. I4 Consequently, individuals with hereditary protein C deficiency suffer from an increased risk of thromboembolic c o m p l i c a t i~n s .~~J~ Two types of protein C deficiency have been describedI7: in type I, the plasma protein C concentration is decreased both functionally and immunologically, and in type 11, only the function is reduced with normal antigen concentration. Phenotypically, with the autosomal tion confirmed the presence of the two mutations. Mutation I would result in a truncated polypeptide of 169 amino acid residues that lacks the heavy chain. Mutation II gives rise to an alteration of a highly conserved amino acid, Gly-376. These data indicate that this patient is a compound heterozygote of the two mutant alleles, each one inherited from each parent. Transient expression assays using COS-7 cells transfected with mutated protein C expression vectors suggested that each of the two mutations leads to the protein C deficiency by causing an impairment of secretion of the respective mutant proteins.
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dominant trait, the heterozygotes may have recurrent venous thrombosis during adult life, while in the autosomal recessive phenotype, the heterozygotes have no symptoms and the homozygotes have a purpura fulminans syndrome during the neonatal period. To confirm the case of homozygous or compound heterozygous protein C deficiency in a neonate with purpura fulminans or massive venous thrombosis, the infant should have undetectable protein C activity and both parents should be heterozygous for protein C deficiency. 16 The cDNAr8J9 and the gene20,21 encoding protein C have been cloned and completely sequenced, and the gene was assigned to chromosome 2.22 In the present study, we characterized a mutant protein C gene from a Chinese patient with severe type I protein C deficiency23 and the protein C genes from his parents and demonstrated two mutant alleles derived separately from the respective parents. Transfection experiments using these mutant genes demonstrated an impairment of secretion of the mutant proteins, resulting in protein C deficiency in this pedigree.
MATERIALS AND METHODS
We studied a Chinese family with congenital protein C deficiency, which we have previously r e p~r t e d ?~ The propositus had no immunologically detectable protein C antigen in his plasma, and the other family members, both parents and the maternal grandfather, had approximately 50% the normal concentration of protein C. The family history showed no consanguity.
Genomic DNA samples prepared from the peripheral blood leukocytes were analyzed by Southern blot hybridization using a cDNA pr0be.2~ The cDNA started at the third codon for the Thr(-24) in the preproleader sequence and extended to 62 bases after the stop codon.
Direct nucleotide sequencing of the genomic DNA amplified by the polymerase chain reaction (PCR) was performed as d e s~r i b e d ?~~~ Primers used in the PCR were chosen from the genomic sequence (Table 1) .
For exon VI and the 349 bp (nucleotides [nt] 8700 to 9048) in exon IX, the PCR was performed with primer pairs slightly changed to introduce EcoRI site within the 5' upstream primer and Hind111 site within the 3' downstream one. (The primer pair for exon VI: 5'-ATC% fiCATCGGCAGCTTCAGCTGCGACT-3' 3151-3181,5'-TCCh kcrri'CCTCCCTAGAAACCCTCCTGA-3' 3565-3536, and the
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s R s n n n STOP pSV2-PCI, making pSV2-PCI-11. The direction and mutations of the exchanged fragment were confirmed by sequencing.
Monkey COS-7 cells were maintained in Dulbecco's Modified Eagle's Medium containing 10% fetal calf serum (FCS). 2 mmollL glutamine, 100 UlmL penicillin, and 100 WglmL streptomycin. For transient expression assays, the plasmid DNAs were introduced into COS-7 cellsby the diet hyl-aminoethyl (DEAE)-dextran-mediated transfection procedure.M Twenty micrograms of each of the four plasmid DNAs, pSV2-PCI-I. pSV2-PCI-11, pSV2-PC1, and pSV2-neo as the negative control, were used per 100-mm dish of COS-7 cells, which had been plated on the previous day (1 x 106 cellslplate). At 72 hours after transfection, with or without an addition of 10 PglmLvitamin KI in the media, total cellular RNA was harvested by the guanidinium thiocyanate method.a Culture media were collected and centrifuged to remove cell debris, and the supernatant was concentrated 10 times with Centricon 10 membrane filters (AmiExpmssion in hetemlqous cells. The truncated amino acid sequence is Indicated below the nucleotide sequence. The newly generated stop codon is underlined and indicated by STOP. The normal amino acid sequence is shown above the nucleotide sequence with amino acid numbers. The emino acid numbering was sta8ted at the aminoterminal residue. alanine, of the light chain. As a result of the 5-nt (CCCGC) deletion indicated by a solid box, a frameshift occurs that leads to replacement of the 35 amino acid residues containing the amino acids of the dipeptide connecting the light and the heavy chains (circled) and the activation peptide at the amino-terminal of the heavy chain.
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con, Beverly, MA). The cells were washed with phosphate-buffered saline (PBS) and suspended in 1 mL of ice-cold lysis buffer (140 mmollL NaCI; IO mmollL Tris. pH 7.4; 1 mmollL EDTA; 0.5% sodium deoxycholate; 1% Nonidet P a , and 1 mmol/L phenylmethanesulfonyl fluoride), and the cell lysate was collected by centrifugation and concentrated by Centricon IO membranes. To measure the transcript levels of the introduced expression vectors. total cellular RNA samples were subjected to Northern blot analysis24 using the protein C cDNA probe. Protein C antigen in the culture media and in the cell lysates was measured by a sandwich-type enzyme-linked immunoadsorbent assay (ELISA). using a rabbit polyclonal anti-human protein C antibody (Asserachrom Protein C Assay Kit, Diagnostica Stago, Asnikres, France). Protein C was also measured by an ELlSA using a horseradish peroxidase-njugated murine monoclonal anti-human protein C antibody, JTC-5,2' as a liquid-phase antibody instead of the enzyme-conjugated polyclonal antibody. 
RESULTS
Southem blot analysis. Purified DNA samples from the patient and his parents were digested with EcoRI, HindIII, and BamHI, and analyzed with the radiolabeled cDNA probe. The protein C genes of the three family members, as well as that of the control individual, showed neither gross deletion nor rearrangement (data not shown).
PCR amplification of genomic DNA and sequence analysis by diwct sequencing. All nine exons and their adjacent intron junctions were amplified by PCR and subjected to direct nucleotide sequencing. Two mutant alleles were identified by sequencing the two asymmetrically synthesized single-stranded DNA..: both the sense and antisense strands for each exon.
Mutation I (5-nt deletion). A deletion of 5 nt (CCCGC) was detected at the end of exon VI. The direct sequencing of the PCR product, which was a mixture of DNA fragments amplified from both parents' alleles, gave rise to a rather complicated pattern of nucleotide bands beyond His-134 (Fig 1A) . Therefore, to confirm this sequence change by sequencing each allele individually, exon VI was separately amplified by the PCR with the oligonucleotide primer pairs that have convenient restriction sites for subcloning into the pUC18 plasmid: the EcoRI site in the 5' upstream primer and the HindIII site in the 3' downstream primer. Subsequently, three normal clones and five mutant clones of plasmid DNA were obtained. Figure 1B shows the sequence of normal and mutant alleles by sequencing the subcloned pUC18 plasmid DNA. This deletion mutation was also identified in the mother's DNA by direct and subcloned DNA sequences. The deletion would result in a stop codon formation due to a frameshift, substituting 35 amino acid residues beyond His-134 (Fig 2) .
A point mutation of G to A occurred in the latter half of exon IX (Fig 3) at nucleotide position 8842, where GGC coding for Gly-376 was changed to GAC coding for aspartic acid. Direct sequencing showed two bases, G and A, at the same nucleotide position 8842 (Fig 3A) . Both alleles of the DNA were separately sequenced by analyzing subcloned PCRamplified fragments inserted into pUCl8 as in the case of mutation I, and the mutation was detected in the patient's and the father's DNAs (Fig 3B) .
PCR and dot blot analysis. To confirm the presence of the two mutational alleles derived from the parents, the regions encompassing the sites of the two mutations, whole exon VI for mutation I and the 349-bp fragment in the exon IX for mutation 11, were amplified by PCR and analyzed by hybridization of allele-specific oligonucleotide probes to the DNA fragment containing each mutation (Fig 4) . In addition to the fact that the two mutations identified were not cloning artifacts, these probes showed that the mother and the father possess mutation I and 11, respectively, and the patient possesses both mutations. These results indicate that the phenotypes and genotypes in this pedigree were compatible.
Mutation I1 (amino acid substitution).
A
While mutation I did not generate or erase any restriction site, mutation I1
abolished an Hue111 restriction site by changing the nucleotide sequence GGCC to GACC at the mutation site. Thus, in the mutant heterozygotes, the patient and the father, Hue111 cleavage of PCR-amplified DNA yielded a longer 247-bp fragment from the mutant allele in addition to the three digested fragments from the normal allele (Fig 5) .
PCR and HaeffI cleavage anabsis.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org Expression in hetemlqgous cells. To ensure that the two identified mutations could cause the deficiency of protein C, we constructed two expression vectors containing the abnormal sequence, pSV2-PCl-I for mutation I and pSV2-PCl-I1 for mutation 11, and transfected them into COS-7 cells for a transient expression assay. Northern blot analysis of the total cellular RNA from the COS-7 cells did not show a significant difference among the transcript levels of normal protein C expression vector, pSV2-PCl, and the two mutant vectors, pSV2-PCl-I and pSV2-PCl-11. An analysis for recombinant protein C in the culture media and in the cell lysates, assayed by the ELISA, is shown in Fig 6. Addition of 10 pg/mL vitamin KI in the culture media did not make any difference in the expression levels. The data indicate that approximately 98% of the normal recombinant protein C synthesized in the COS-7 cells was secreted into the culture media and that the levels of the two mutants of protein C secreted into the media were only 1% to 3% of the level of the normal recombinant protein secreted, although the mutants were present in the cells in amounts comparable to that of the normal recombinant protein C. When we measured the protein C levels by an ELISA using monoclonal antibody JTC-5 instead of polyclonal antibody as an cnzyme-conjugated fluid-phase antibody, we could not detect protein C produced by the cells transfected with pSV2-PC1-I (mutant I), although the results obtained with pSV2-PCl (normal) and pSV2-PCl-I1 (mutant 11) were consistent with those shown in Fig 6. Since JTCJ recognizes an epitope in the heavy chain of protein C, the result supports the prediction that mutant I is devoid of the heavy chain. 
DISCUSSION
In the present study, we analyzed the gene for protein C of a patient with protein C deficiency with neonatal purpura fulminans and undetectable plasma protein C antigen (severe type I deficiency). Both of his parents were heterozygous for the deficiency, and we found by direct nucleotide sequencing that the patient was a compound heterozygote of the two mutant alleles, each mutant allele inherited from each parent.
One of the mutations is a nucleotide deletion leading to a frameshift (mutation I), which was inherited from the mother. A deletion of 5 nt (CCCGC), nucleotide position 3447 to 3451, corresponding to amino acids Pro-135 (CCC) and GC in Ala-136 (GCA), was detected in the end portion of the exon VI. The predicted effect of this deletion mutation on the protein structure is shown in Fig 2. The consensus nucleotide sequence for the splice junction boundary between exon VI and intron F is preserved as CAG/GTG (Fig 1) .)2 and a reading frameshift due to the deletion leads to the generation of a new stop codon in exon VII, which is located 35 residues beyond His-134 (Fig 2) . This change would result in a truncated polypeptide of 169 amino acid residues that lacks the heavy chain of protein C and is approximately 46% of the normal size, in which a Lys-Arg dipeptide connecting the light chain to the heavy chain is missing and the NH2-terminal 12-residue activation peptide could not be constructed (Fig 2) . The lack of the heavy chain was supported by the finding that a monoclonal antibody that recognizes an epitope in the heavy chain of protein C failed to detect recombinant mutant I. 
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role in the construction of the normal enzyme structure. Third, the alteration of Gly, an amino acid of neutral capacity, to Asp, an amino acid that is negatively charged, should have significantly changed the hydrophobicity of the region encompassing the neighboring amino acids. The significant alteration in the hydrophobicity may cause a conformational change by disrupting the normal hydrogenbonding network responsible for maintaining the tertiary structure. Construction of three-dimensional structure models based on a known crystal structure of a serine protease should reveal the possible effect of the mutation on the protein conformation.
Despite the perfect conservation of the glycine residue equivalent to Gly-376 in the protein C gene, the alteration of the corresponding amino acid has not been reported in the 11 other serine proteases listed in Fig 7. In the case of factor IX, which has the greatest similarity in sequence to protein C, genetic abnormalities of the gene have been characterized in detail as the cause of hemophilia B.44 Although many point mutations leading to an alteration of an amino acid in the catalytic domain have been reported, no mutation of Gly-381 in the factor IX gene (corresponding to G1y-376 Of protein c, has been described.
To confirm that mutation I and I1 really gave rise to the type 1 deficiency in plasma, we performed experiments in which each of the mutated genes was transfected into cultured cells for expression. The data obtained provide strong evidence for the impairment of the secretory processes of the two mutants of protein C, for each of these mutations reduced the amount of each of the mutant proteins secreted into the media to 1% to 3% of that of normal recombinant protein C, while they were present in the cells in an amount comparable to that of the normal recombinant protein C (Fig 6) . The cellular content of the mutant protein C produced in pSV2-PC1-11-transfected cells (mutant 11) was significantly higher than that of the normal recombinant protein C (Fig 6) . The cellular content of the other mutant protein C produced in pSV2-PCl-Itransfected cells (mutant I) was less than that of the normal recombinant protein C when the amounts were expressed in nanograms (Fig 6) . However, if the amounts are expressed in moles, the amount of the mutant I would be higher than that of the normal recombinant protein C, since the predicted molecular weight of the mutant I is less than a half of that of the normal protein C. These data suggest that The other mutation is a point mutation resulting in an amino acid substitution (mutation 11), and this was derived from the father. The point mutation of G to A at a nucleotide position 8842, where Gly-376 (GGC) was changed to Asp (GAC), was identified in exon IX, located in the catalytic domain of the protein. Because there is yet insufficient information on the tertiary structure of protein C, it is difficult to predict the effect of the amino acid substitution Gly-376 to Asp on the conformation of the molecule. Nevertheless, a significant effect of this amino acid substitution on the serine protease domain of the protein can be presumed in some aspects. First, Gly-376 is located in the catalytic domain of the protein: the 29-amino acid loop created by the disulfide bond (Cys-356 and Cys-384) that contains the active site Ser-360. Second, Gly-376 is a highly conserved amino acid, as compared with 11 other serine proteases (Fig 7) .33-43 The perfect conservation of Gly-376 strongly suggests that it plays an important Truncation of the molecule (mutant I) and a conformational change (mutant 11) should have affected their posttranslational transport through intracellular secretory compartments. Instability of the mutant proteins may also be suggested, because no abnormal accumulation of the proteins was observed, despite the retarded secretion. The mutations did not have a significant effect on the transcript level as tested with the RNA blot analysis in the heterologous transfection system. These results suggest that instead of being secreted from the cells, most of the mutant protein C molecules undergo degradation within the cells, while their transports are retarded in the intracellular secretory pathways; thus, the mutations I and I1 should lead to protein C deficiency primarily by causing an impairment of protein C secretion into plasma.
We have previously shown that hereditary deficiencies of a*-plasmin inhibitor in two unrelated families are caused by impaired intracellular transport of the mutant p r 0 t e i n s . 4~~~ The mutated a2-plasmin inhibitor proteins lead to the deficiencies primarily by causing a block in the intracellular transport from the endoplasmic reticulum to the Golgi complex within the liver cells. Several transport-deficient mutants have also been reported to cause the hereditary al-antitrypsin deficiencies.& In addition to these mutants of serine protease inhibitors, two kinds of mutations of a serine protease, protein C, were demonstrated to generate transport-deficient mutants in the present study. Thus, it is speculated that the impaired intracellular transport should be one of the prevalent causes for the deficiencies of plasma proteins, including those involved in coagulation and fibrinolysis. We propose to call each allele of this compound heterozygote protein C deficiency Hong Kong 1 and 2 for mutation I and 11, respectively. For personal use only. on September 14, 2017. by guest www.bloodjournal.org From
